Skip to main content
. 2017 Oct 1;2(1):265–273. doi: 10.1089/can.2017.0036

FIG. 2.

FIG. 2.

Structures of the putative GPR3, GPR6, and GPR12 endogenous ligands S1P and SPC and the GPR3 and GPR6 inverse agonist CBD. SPC, sphingosylphosphorylcholine.